BioSpace News Archive

Business

BIOREM Reports 8% Increase in Revenue, Earnings of $4.7 million and EPS of $0.12

BIOREM Inc. (TSX-V: BRM) (“BIOREM” or “the Company”) today announced its results for the three and twelve-month periods ended December 31, 2018.

March 18, 2019
·
3 min read
BioForest

Prevencio Announces Two Validation Studies Confirming High Accuracy of Novel HART AI-driven Tests

Compelling Data for HART CVE™ Test for Cardiovascular Events and HART CAD™ Test for Coronary Artery Disease

March 18, 2019
·
5 min read
Business

Bryan Reasons Joins Mallinckrodt as the Company’s Chief Financial Officer (CFO)

Brings substantial CFO, finance expertise and pharmaceutical industry experience

March 18, 2019
·
4 min read
Biotech Bay

BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

BioPharmX Corporation today announced presentations at multiple upcoming investor conferences.

March 18, 2019
·
1 min read
Genetown

Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women’s Cancer

Leap Therapeutics, Inc. announced the presentation of clinical data from its ongoing Phase 2 clinical trial of DKN-01 in patients with advanced gynecological malignancies at the Society of Gynecologic Oncology 50th Annual Meeting on Women’s Cancer.

March 18, 2019
·
8 min read
Pharm Country

Bruker Highlights New Systems and Applied Market Solutions at Pittcon

At Pittcon 2019, Bruker this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions.

March 18, 2019
·
9 min read
Business

PolarityTE Reports Results and Corporate Update for Two-Month Transition Period Ended December 31, 2018

PolarityTE, Inc. today reported financial results for the two-month transition period that ended December 31, 2018.

March 18, 2019
·
9 min read
Business

RDD Pharma Appoints John Temperato as Chief Executive Officer

RDD Pharma, Inc. today announced the appointment of industry veteran John Temperato as Chief Executive Officer.

March 18, 2019
·
2 min read
Pharm Country

Soligenix to Present at National Institutes of Health - Commercialization Accelerator Program “FeedForward Session” in Washington, DC

Soligenix, Inc. announced today that they will be presenting at the National Institutes of Health (NIH) – Commercialization Accelerator Program (CAP) “FeedForward Session” in Washington, DC on March 21, 2019.

March 18, 2019
·
11 min read
BioForest

Kit Check™ and Avery Dennison Partner to Improve Patient Safety by Integrating RFID into cGMP Packaging Lines

RFID technology improves accuracy and visibility of the medication supply chain, from the production line to the patient

March 18, 2019
·
4 min read